Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination Ann Hematol (2017) 96:1563–1568 DOI 10.1007/s00277-017-3062-2 LETTER TO THE EDITOR Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination 1 2 1 Neeraj Saini & Rajneesh Nath & Jan Cerny Received: 12 January 2017 /Accepted: 3 July 2017 /Published online: 15 July 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, We evaluated outcomes of a CNI-free GVHD prophylaxis Acute or chronic graft-versus-host disease (GVHD) has regimen of SIR-MMF [sirolimus (SIR) combined with myco- been the nemesis for allogeneic hematopoietic stem cell trans- phenolate mofetil (MMF)] for patients with hematological plantation (HSCT). Initial efforts in GVHD prophylaxis malignancies. A total of six patients (four males and two fe- established cyclosporine A (CsA), a calcineurin inhibitor males) underwent reduced intensity conditioning (RIC) (CNI), to be more effective as a single agent compared to matched (10/10) unrelated donor peripheral blood stem cell methotrexate [1]. The combination of cyclosporine, a CNI, transplant (PBSCT) at our institution from April to June in the with methotrexate has been the standard regimen for acute year 2011. The median age of the group was 68 years (65– GVHD prophylaxis for the last three decades [2]. Prior studies 77 years). Three patients had acute myelogenous leukemia in of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Hematology Springer Journals

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination

Loading next page...
 
/lp/springer_journal/calcineurin-inhibitor-free-gvhd-prophylaxis-with-sirolimus-and-tVAXLwNO0r
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Hematology; Oncology
ISSN
0939-5555
eISSN
1432-0584
D.O.I.
10.1007/s00277-017-3062-2
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial